AZ gives Galliard UK prostate remit

Galliard Healthcare Communications has scooped the UK PR remit for AstraZeneca’s prostate cancer treatment, Casodex.

News of the win emerged after last week’s appointment of Cohn & Wolfe to handle the brand’s global PR (PRWeek, 13 February).

Both had been handled by Burson-Marsteller, which pitched for the UK contract alongside agencies including Packer Forbes Communications and Munro & Forster.

Galliard director Sarah Ackers reports to AstraZeneca brand comms manager Isabelle Jouin.

UK PR for Zoladex, another AstraZeneca prostate cancer drug, whose global remit was won by C&W last week, is handled on an ad hoc basis by Chandler Chicco Agency.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in